All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study

@article{Fleming2012AllcauseMI,
  title={All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study},
  author={Kate M Fleming and Guruprasad Padur Aithal and Timothy R Card and Joe West},
  journal={Liver International},
  year={2012},
  volume={32}
}
BACKGROUND Mortality due to cirrhosis has tripled over the last 30 years in the UK. [] Key MethodMETHODS In a cohort study, we identified 4537 people with cirrhosis and a control cohort of 44 403 patients, matched by age, sex and general practice from the UK General Practice Research Database between June 1987 and April 2002.

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis

To compare the risks of all‐cause mortality, hepatic outcomes, major adverse cardiovascular events between metformin users and nonusers for patients with diabetes and cirrhosis.

The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)

TLDR
Two survival models that included parameters commonly recorded in routine clinical practice were generated that reliably forecast the risk of death in patients with cirrhosis: in the acute, post diagnosis phase, and following this critical, 90 day phase.

Treatment of Patients with Cirrhosis.

This guide to the practical treatment of patients with cirrhosis summarizes recent developments. It includes advice on medical management, invasive procedures, nutrition, prevention, and strategies

Survival and risk factors related to death in outpatients with cirrhosis treated in a clinic in Southern Brazil

TLDR
Patients with cirrhosis monitored on an outpatient basis, despite showing a reasonable survival rate, have a worse prognosis when the etiology of liver disease is related to hepatitis C virus and when they have hepatocellular carcinoma or hypoalbuminemia.

Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study

TLDR
The incidence of AH and alcoholic liver cirrhosis is increasing and the survival is poor and most deaths are alcohol-related and other common causes of excess deaths are cancers especially in the upper aerodigestive tract and cardiovascular, digestive and respiratory diseases as well as violence and accidents.

Epidemiology of alcoholic liver disease in Korea

TLDR
The recent epidemiology of alcoholic liver disease in Korea is summarized in order to summarize the country's rapid socioeconomic development and alcohol consumption.

Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis

TLDR
The risks of all‐cause mortality, major adverse cardiovascular events (MACE) and hepatic outcomes between patients with T2DM and cirrhosis using and not using thiazolidinedione (TZD) are compared.

Long-Term Outcome of Cardiac Surgery in 1,040 Liver Cirrhosis Patient - Nationwide Population-Based Cohort Study.

TLDR
Even after successful cardiac surgery, long-term outcome is unsatisfactory in LC patients because of the progressive deterioration of liver function and those with valve surgery and advanced cirrhosis had a lower survival rate.

Role of Comorbidities in the General Management of Compensated Cirrhosis, Including Malnutrition

TLDR
Comorbidities in need of surgery, the most frequent gallstones and hernia, are also a frequent clinical problem to face since the intervention may increase the risk of decompensation and mortality.

Survival Analysis of Hospitalized Liver Cirrhotic Patients in Jakarta: 2 Years Follow Up Study

TLDR
The mortality rate of liver cirrhotic patients is very high with infection as the main COD, and patients with Child-Pugh score B and C have worse prognosis than Child- Pugh score A.
...

References

SHOWING 1-10 OF 16 REFERENCES

Comorbidity and survival of Danish cirrhosis patients: A nationwide population‐based cohort study

TLDR
In the first year of follow-up, but not later, comorbidity increased the risk of Cirrhosis‐related death, and this was consistent with an apparent synergy between the cirrhosis and comor bidity effects on mortality in the same period.

Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999

TLDR
The high mortality rates after hospital admission, and the fact that they have not fallen in the past 30 years, show that liver cirrhosis remains a disease with a very poor prognosis.

A 20-year prospective study of cirrhosis.

TLDR
Since alcoholic cirrhosis is now the most common form of the disease it is important to recognise those at risk and to encourage abstinence; also, more efforts are needed to identify the causes of cryptogenic Cirrhosis.

Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002

TLDR
Mortality for patients hospitalized with esophageal varices in Sweden decreased between 1969 and 2002, and this suggests that the use of new treatment strategies both for acute variceal hemorrhage and secondary prophylaxis has had an impact on prognosis.

Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs

TLDR
Between the years 1981–1982 and 1988–1991, improvements in long-term survival after an initial episode of esophageal variceal hemorrhage resulted primarily from better short-term mortality and sclerotherapy offers a partial explanation for improved survival.

Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data

Survival and prognostic indicators in compensated and decompensated cirrhosis

Six-year survival of cirrhosis was assessed in a series of 1155 consecutive patients (751 men, 404 women). Among the men, 33% were alcoholics and 18% were HBsAg positive; corresponding figures for

Natural history of patients hospitalized for management of cirrhotic ascites.

  • R. PlanasS. Montoliu R. Solá
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2006